FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

386897000: Lamivudine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
1461075018 Lamivudine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)
1481011010 Lamivudine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)
1491831012 3TC en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lamivudine (substance) Is a Organic nitrogen compound true Inferred relationship Some
Lamivudine (substance) Is a Anti-infective agent (substance) true Inferred relationship Some
Lamivudine (substance) Is a Substance categorized by disposition true Inferred relationship Some
Lamivudine (substance) Has disposition (attribute) Disposition true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Some 1
Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Lamivudine (substance) Inferred relationship Some 1
Lamivudine 150 mg oral tablet Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Some 1
Lamivudine 150 mg oral tablet Has precise active ingredient True Lamivudine (substance) Inferred relationship Some 1
Lamivudine 150 mg and zidovudine 300 mg oral tablet Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Some 1
Lamivudine 150 mg and zidovudine 300 mg oral tablet Has precise active ingredient True Lamivudine (substance) Inferred relationship Some 1
Lamivudine only product Has active ingredient True Lamivudine (substance) Inferred relationship Some 1
Product containing precisely efavirenz 400 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Some 1
Product containing precisely efavirenz 400 milligram and lamivudine 300 milligram and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Lamivudine (substance) Inferred relationship Some 1
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Some 1
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet Has precise active ingredient True Lamivudine (substance) Inferred relationship Some 1
Lamivudine 30 mg and zidovudine 60 mg oral tablet Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Some 1
Lamivudine 30 mg and zidovudine 60 mg oral tablet Has precise active ingredient True Lamivudine (substance) Inferred relationship Some 1
Product containing precisely abacavir (as abacavir sulfate) 120 milligram and lamivudine 60 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Some 1
Product containing precisely abacavir (as abacavir sulfate) 120 milligram and lamivudine 60 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has precise active ingredient True Lamivudine (substance) Inferred relationship Some 1
Product containing precisely lamivudine 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has basis of strength substance (attribute) True Lamivudine (substance) Inferred relationship Some 1
Product containing precisely lamivudine 10 milligram/1 milliliter conventional release oral solution (clinical drug) Has precise active ingredient True Lamivudine (substance) Inferred relationship Some 1
Product containing only dolutegravir and lamivudine and tenofovir (medicinal product) Has active ingredient True Lamivudine (substance) Inferred relationship Some 1
Lamivudine and nevirapine and zidovudine only product Has active ingredient True Lamivudine (substance) Inferred relationship Some 1
Product containing only abacavir and lamivudine (medicinal product) Has active ingredient True Lamivudine (substance) Inferred relationship Some 1
Product containing only lamivudine and zidovudine (medicinal product) Has active ingredient True Lamivudine (substance) Inferred relationship Some 1
Efavirenz and lamivudine and tenofovir only product Has active ingredient True Lamivudine (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start